Parkinson's disease
Would you like to receive a message when there is new research about Parkinson's Disease? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as new research on Parkinson's Disease is published. View what Premium costs.
Publications and studies (3515)
- MANAGE-PD and clinician recommendations for device-aided therapy in Parkinson's disease: Insights from a Turkish tertiary movement disorders cohort. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of Parkinson Disease. (2026/08/04) ♡
- Association between PCSK9 targeted therapy and the risk of stroke and dementia: A Meta-Analysis of Randomized Controlled Trials. (2026/08/04) ♡
- Catalpol protects against MPP(+)-induced neurotoxicity by targeting PINK1/DJ-1-mediated mitophagy and the TrkB/Akt/BDNF/Bcl-2 axis. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An updated patent review of mGlu5 negative allosteric modulators (2018 - present). (2026/08/04) ♡
- MRI-based glymphatic metrics correlate with caudate nucleus dopaminergic deficits and are independent of amyloid-β pathway in Parkinson's disease. (2026/08/04) ♡
- The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial. (2026/08/03) ♡
- Ketogenic β-hydroxybutyrate-regulated β-hydroxybutyrylation of HSPE1 alleviates neuronal apoptosis in MPTP/MPP(+) induced Parkinson's disease models. (2026/08/03) ♡
- Wearable gait analysis for differentiating progressive supranuclear palsy and Parkinson's disease: Clinically interpretable digital biomarkers using machine learning. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence. (2026/08/03) ♡
- Gut microbial dysbiosis in a Southern Chinese cohort of patients with Parkinson's disease. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Multimorbidity in neurodegenerative diseases]. (2026/08/01) ♡
- Delta-opioid receptor-mediated neural protection and regeneration. (2026/08/01) ♡
- Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson Disease: An Examination of Exercise Intensity. (2026/08/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Enhancing Asleep Deep Brain Stimulation Targeting for Essential Tremor Using Machine Learning: The OPTIVIM Phase 2 Study. (2026/08/01) ♡
- Position Statement of the American Society for Stereotactic and Functional Neurosurgery on Focused Ultrasound Lesioning of the Brain by Non-neurosurgeons. (2026/08/01) ♡
- Using Multinodal Deep Brain Stimulation for Treatment of Complex Movement Disorders: Initial Case Series. (2026/08/01) ♡
- Comparison of Anatomical Landmarks and Atlas- and Automated Atlas Segmentation Application-Based Targeting in Magnetic Resonance Imaging-Guided Focused Ultrasound Ventralis Intermedius Thalamotomy. (2026/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Acupuncture inhibits autophagy and promotes synaptic repair by activating the PI3K/Akt/mTOR pathway in a rat model of depression in Parkinson's disease. (2026/08/01) ♡
- Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment. (2026/08/01) ♡
- Prebiotics and SCFA Alleviate Parkinson's-Related Constipation: Results from a Randomized Controlled Trial. (2026/08/01) ♡
- Accelerated Biological Aging, Neurodegenerative Disease, and Mortality in Cardiovascular Disease Patients: Mediation and Modification Analysis. (2026/08/01) ♡
- Dorsal raphe tau pathology disrupts sleep-wake orchestration and sleep architecture in a sex-specific manner. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Reprogramming of Brain Microglia: Implications for Aging and Aging-Associated Neurodegenerative Diseases. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress of traditional Chinese medicine interventions for aging-related nervous system diseases. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-pharmacological and non-surgical therapies in advanced Parkinson's disease: a narrative review and call to action. (2026/08/01) ♡
- Gender-Specific Lipid Parameters Predict Excessive Daytime Sleepiness in Parkinson's Disease. (2026/08/01) ♡
- Oleuropein regulates neuronal survival and Histone acetylation in Parkinson's disease: cellular and epigenetic insights. (2026/07/31) ♡
- Integrative network pharmacology, transcriptomics, and molecular docking identify candidate Centella asiatica constituents and targets in neurodegenerative diseases. (2026/07/31) ♡
- A Narrative Review: Suvorexant's Role in Sleep Deprivation and Neurodegenerative Disease. (2026/07/30) ♡
- Alterations in brain physiological pulsations in Parkinson's disease: a case-control study. (2026/07/30) ♡
- Lipid-conjugated Ru(iii) complexes as inhibitors of pathological peptide aggregation in neurodegenerative disorders. (2026/07/29) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Suicide in neurodegenerative diseases: a systematic review. (2026/07/29) ♡
- Sarsasapogenin Improves Pathological Phenotypes in MPTP/MPP(+)-Induced Parkinson's Disease Models: Synergistic Actions of Neurite Outgrowth, Neurotransmitter Modulation, and Anti-Inflammation. (2026/07/29) ♡
- Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A framework for multidisciplinary management of autonomic dysfunction in Parkinson disease. (2026/07/29) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Integrated In Vivo and In Vitro Analysis of Alpha-Synuclein Aggregation and Neuroinflammatory Amplification in a Composite Parkinson's Disease Model. (2026/07/29) ♡
- When the inner clock fades: Interoceptive decline and consolidation of phase resetting in cortical rhythms by cardiac events underlie healthy lifespan aging. (2026/07/29) ♡
- An Overview of 1,2,4-Triazole-5-Thiol and 3-Thione Derivatives as Promising Scaffolds for Anti-Neuroinflammatory Drug Discovery. (2026/07/28) ♡
- The Double-Edged Sword: A Structured Narrative Review of Microglial Phenotypic Transition as a Pivotal Driver and Therapeutic Target in Parkinson's Disease. (2026/07/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Subacute Exposure to Macrocyclic Lactone Insecticides Induces Parkinson's Disease-like Motor Deficits and Neuropathology in Mice. (2026/07/28) ♡
- STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Probiotics and Plant Extracts in the Gut-Brain Axis: Mechanisms, Interactions, and Clinical Perspectives. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Reproducible Generalized Thermal Sensation Triggered by Levodopa in a Patient With Parkinson's Disease. (2026/07/28) ♡
- Bioinformatic Tools to Explore the Mechanisms and the Multitarget Recognition of Huperzine A in Alzheimer's and Parkinson's Diseases. (2026/07/28) ♡
- What do people with Parkinson's think about telerehabilitation? A thematic analysis of patient interviews. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. α-Synuclein burden amplification in Parkinson's disease: a unified genetic, molecular, and cellular framework. (2026/07/27) ♡
- Operational, molecular, and cultural perspectives at the Neurological Foundation Human Brain Bank, New Zealand. (2026/07/27) ♡
- ScaleSpecter: a frequency-aware multi-scale patch framework for robust physiological classification under non-stationarity. (2026/07/27) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.